Internal Medicine, Hematology · Nashville, TN
NPI
1437565652
Since 2014
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3601 the Vanderbilt Clinic
Nashville, TN, 37232
Phone (615) 322-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
367 services
Medicare patients, 2024
114
Average age 73
Drug cost, 2024
$3.3M
231 prescriptions
Company payments, 2025
$23K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashwin Kishtagari was code 99233 (hospital e&m - subsequent), 97 times for 25 patients. In total Ashwin Kishtagari billed 367 services in 12 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 97 | 25 | $80.70 | $7,828 |
| 99215 Office E&M - Established | Facility | 78 | 41 | $98.29 | $7,667 |
| 99214 Office E&M - Established | Facility | 64 | 41 | $61.52 | $3,937 |
| 99205 Office E&M - New | Facility | 21 | 21 | $119.89 | $2,518 |
| 99222 Hospital E&M - Initial | Facility | 13 | 13 | $88.31 | $1,148 |
| 99223 Hospital E&M - Initial | Facility | 12 | 12 | $127.30 | $1,528 |
| 99239 Hospital Discharge Management | Facility | 11 | 11 | $83.96 | $924 |
By year: 2022 $43K for 585 services; 2023 $43K for 545 services; 2024 $29K for 367 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ashwin Kishtagari prescribed most often to Medicare patients was Vonjo (Pacritinib Citrate), with 40 prescriptions and refills. In total Ashwin Kishtagari wrote 231 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vonjo Pacritinib Citrate | 40 | 40 | Under 11 | $1.0M |
| Jakafi Ruxolitinib Phosphate | 32 | 32 | Under 11 | $553K |
| Ayvakit Avapritinib | 23 | 23 | Under 11 | $906K |
| Hydroxyurea Generic | 17 | 42 | Under 11 | $452 |
| Valacyclovir Valacyclovir Hcl | 14 | 26 | Under 11 | $847 |
| Venclexta Venetoclax | 12 | 12 | Under 11 | $120K |
Brand drugs: 140 claims; generic drugs: 91 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashwin Kishtagari $23K ($23K in general payments such as food, travel and fees) from 11 companies. The largest payer was Sobi, Inc with $7,644.
| Company | Payments | Amount |
|---|---|---|
| Sobi, Inc SOBI.ST | 8 | $7,644 |
| Geron Corporation GERN | 10 | $5,744 |
| Syndax Pharmaceuticals, Inc. SNDX | 2 | $2,393 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $2,248 |
| Blueprint Medicines Corporation SNY | 3 | $2,184 |
| Siemens Medical Solutions USA, Inc. SHL.DE | 1 | $1,035 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $850 |
| Daiichi Sankyo Inc. 4568.T | 1 | $650 |
| Rigel Pharmaceuticals, Inc. RIGL | 1 | $131 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.